SIC
TNDM icon

SJS Investment Consulting’s Tandem Diabetes Care TNDM Stock Holding History

SJS Investment Consulting’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49K Sell
165
-156
-49% -$2.72K ﹤0.01% 1682
2026
Q1 		$6.15K Buy
321
+310
+2,818% +$6.74K ﹤0.01% 985
2025
Q4 		$242 Buy
+11
New +$199 ﹤0.01% 1750

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

SJS Investment Consulting's TNDM Position: Q2 2026 in Review

SJS Investment Consulting reduced its Tandem Diabetes Care (TNDM) stake by 49% in Q2 2026, selling an estimated $2.72K and leaving 165 shares worth $2.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1682.

SJS Investment Consulting first reported a position in TNDM in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.15K in Q1 2026. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • SJS Investment Consulting held 165 shares of Tandem Diabetes Care worth $2.49K as of Q2 2026.
  • SJS Investment Consulting sold 156 Tandem Diabetes Care shares in Q2 2026, an estimated $2.72K.
  • Tandem Diabetes Care made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1682 holding.
  • SJS Investment Consulting first reported a position in Tandem Diabetes Care in Q4 2025 and has held it in 3 quarters since.
  • SJS Investment Consulting's Tandem Diabetes Care position peaked at $6.15K in Q1 2026.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.